Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Afynia Laboratories logo — Your trusted source for information and fast, easy-to-use pr...

Afynia Laboratories

Your trusted source for information and fast, easy-to-use products for women’s health conditions.

Founded 2021 Canada Hamilton, Canada 6 employees Grant Total: $180.00K

General Information

Company Name Afynia Laboratories
Founded Year 2021
Location Canada Hamilton, Canada
Employees 6
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Afynia Laboratories. To contact Afynia Laboratories, visit afynia.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Afynia Laboratories

Afynia Laboratories is a Canadian FemTech startup, formerly known as AIMA Laboratories, founded in 2021. Co-founded by two scientists specializing in reproductive endocrinology and infertility, the company aims to address gaps in women's health. Their flagship product targets chronic pelvic pain, menstrual pain, and infertility caused by endometriosis, offering clarity and peace-of-mind. With a mission to develop innovative solutions for women's health conditions, Afynia Laboratories envisions becoming a prominent player in the international women’s health marketplace.

The latest investment of $30.00K came in the form of a grant from i.d.e.a. Fund on 14 June 2023. Contact them at [email protected] for more information.

Taxonomy: FemTech, Women's Health, Reproductive Endocrinology, Infertility, Endometriosis, Medical Research, Pre-clinical, Health Products, Chronic Pelvic Pain, Menstrual Pain, International Expansion

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $150.00K 1
Ontario Genomics
14 Jun 2023
Grant $30.00K 1
i.d.e.a. Fund
i.d.e.a. Fund
14 Jun 2023

Afynia Laboratories Alternatives & Competitors

View All Alternatives
Afynia Laboratories vs
Zencape Health
Zencape Health United States

We’re on a mission to close the gender pain gap, starting with chronic pelvic conditions.

2 employees
Health Care, Health and Wellness
Afynia Laboratories vs
Center for Human Reproduction
Center for Human Reproduction United States

Over 30 Years Leading in Infertility Care Serving Patients Worldwide

39 employees
Health Care
Afynia Laboratories vs
Materna Medical
Materna Medical United States

A Fast Company 2021 World Changing Ideas Finalist: "Empowering women to protect and restore their pe...

Series B
44 employees
Health Care, Medical Devices
View all alternatives

FAQ About Afynia Laboratories

Your trusted source for information and fast, easy-to-use products for women’s health conditions.
Afynia Laboratories was founded in 2021.
Afynia Laboratories is headquartered in Hamilton, Canada.
Afynia Laboratories has approximately 6 employees.
Afynia Laboratories has completed 2 funding rounds, raising a total of $180.00K. The latest funding stage is Grant.
Top alternatives and competitors to Afynia Laboratories include Zencape Health, Center for Human Reproduction, Materna Medical, NORTHERN CALIFORNIA RESEARCH , Extend Fertility. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Afynia Laboratories and Zencape Health are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Afynia Laboratories, https://bouncewatch.com/company/afynia-laboratories, updated 20 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes